Related Experiment Video
Updated: Sep 21, 2025
06:24
Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
Published on: January 10, 2025
938
Removal of Isotretinoin Gender-Based Guidelines: Inclusivity Takes Precedence
1University of Oklahoma, Oklahoma City.
Cutis
|June 6, 2022
Summary
The iPLEDGE Risk Evaluation and Mitigation Strategy (REMS) system now uses inclusive categories for isotretinoin prescriptions. This change focuses on pregnancy potential, not gender, for safer patient care.
Area of Science:
- Dermatology
- Pharmacovigilance
- Public Health
Background:
- The iPLEDGE Risk Evaluation and Mitigation Strategy (REMS) is a program for isotretinoin.
- Previous REMS categories were based on gender and reproductive potential.
- Advocacy by physicians and patients led to significant program changes.
Purpose of the Study:
- To detail the recent structural changes in the iPLEDGE REMS system.
- To explain the shift towards more inclusive patient risk categorization.
- To propose patient-centered questions for assessing isotretinoin risks.
Main Methods:
- Review of the updated iPLEDGE REMS program structure.
- Analysis of the new risk categories: "people who can get pregnant" and "people who cannot get pregnant".
- Development of patient-facing questions regarding pregnancy risks.
Main Results:
- The iPLEDGE REMS system has been restructured for greater inclusivity.
- Risk categories are now based on pregnancy potential rather than gender.
- New questions aim to better understand individual patient risks.
Conclusions:
- The updated iPLEDGE REMS promotes a more inclusive, patient-centered approach to isotretinoin prescribing.
- This change aligns with the goal of providing equal care for all patients.
- The revised system facilitates a better understanding of pregnancy-related risks.
More Related Videos
Related Concept Videos
01:23Drug Elimination: Non-Renal Routes
2.5K
The liver plays a pivotal role in eliminating drugs and their metabolites, primarily through a process known as biliary excretion. This process involves the hepatocytes, the primary cells in the liver that generate bile. A range of transporters actively expels polar drugs or hydrophilic drug metabolites into the bile, which transports the drugs and metabolites into the small intestine. From here, they are eventually expelled from the body through feces. In some instances, the original drug or a...
2.5K
01:22Drug Elimination by Renal Route: Tubular Reabsorption
4.0K
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
4.0K
01:17Drug Elimination by Renal Route: Glomerular Filtration
6.0K
The kidney serves as the primary organ responsible for eliminating drugs and their metabolites from the body. This process, known as renal elimination, starts with glomerular filtration and results in urine formation. Each kidney houses millions of functional units called nephrons, where urine production takes place. A nephron has two main components: a renal corpuscle and a renal tubule. Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent...
6.0K
01:15Drug Elimination by Renal Route: Tubular Secretion
2.6K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.6K
01:06Drug Elimination: The Concept of Clearance
3.1K
Drug elimination refers to removing drugs from the body, either through urine by the kidneys or through bile by the liver. Drug clearance is a pharmacokinetic parameter that measures the efficiency of drug removal from the bloodstream within a specific time frame. It is calculated as the rate at which a drug is eliminated from plasma divided by the plasma concentration of the drug.
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination,...
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination,...
3.1K
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
900
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
900